Fund HoldingsACUTA CAPITAL PARTNERS, LLC

Total Portfolio Value
$153.94M
Total Bought
$40.25M
Total Sold
$90.47M
Net Transaction
-$50.21M
Filing Period:
Securities
SharesValue ($K)
Q4 2023
Q1 2024
Change
Q4 2023
Q1 2024
Weight (%)
Change
OCULAR THERAPEUTIX INC(OCUL)1,310,0002,635,287+1,325,2875,84323,98115.58%+18,139
ENLIVEN THERAPEUTICS INC123,876396,099+272,2231,7146,9674.53%+5,253
MERSANA THERAPEUTICS INC2,368,0002,164,628-203,3725,4949,6986.30%+4,204
APPLIED THERAPEUTICS INC525,100792,000+266,9001,7595,3863.50%+3,627
DYNE THERAPEUTICS INC(DYN)147,836184,500+36,6641,9665,2383.40%+3,272
PRAXIS PRECISION MEDICINES I(PRAX)299,636162,302-137,3346,6769,9046.43%+3,228
TAYSHA GENE THERAPIES INC(TSHA)3,589,3333,333,333-256,0006,3539,5676.21%+3,214
CELLDEX THERAPEUTICS INC(CLDX)69,400109,000+39,6002,7524,5752.97%+1,822
AGIOS PHARMA(AGIO)055,262+55,26201,6161.05%+1,616
SAREPTA THERAPEUTICS INC(SRPT)70,60064,162-6,4386,8088,3065.40%+1,498
ORIC PHARMACEUTICALS INC(ORIC)0103,992+103,99201,4300.93%+1,430
MEREO BIOPHARMA GROUP PLC0397,884+397,88401,3130.85%+1,313
LYRA THERAPEUTICS INC0173,320+173,32001,0780.70%+1,078
ULTRAGENYX PHARMACEUTICAL INC(RARE)020,000+20,00009340.61%+934
INTRA-CELLULAR THERAPIES INC.013,300+13,30009200.60%+920
INSMED INC(INSM)29,50061,718+32,2189141,6741.09%+760
AADI BIOSCIENCES INC1,849,4021,849,40203,7364,3282.81%+592
CRINETICS PHARMACEUTICALS(CRNX)87,50078,403-9,0973,1133,6702.38%+557
VERASTEM INC232,249207,095-25,1541,8912,4441.59%+553
REVOLUTION MEDICINES INC(RVMD)160,000143,777-16,2234,5894,6343.01%+45
NUVATION BIO(NUVB)90,83290,83205270.02%+22
ANAVEX LIFE SCIENCES CORP(Put)1,0000-1,000230-22
TOURMALINE BIO INC231,882261,108+29,2266,0715,9793.88%-91
TYRA BIOSCIENCES INC(TYRA)8,8670-8,8671230-123
VAXCYTE INC(PCVX)117,373104,830-12,5437,3717,1614.65%-210
CENTESSA PHARMACEUTICALS PLC38,1380-38,1383040-304
SPRINGWORKS THERAPEUTICS INC10,0000-10,0003650-365
VERONA PHARMA PLC19,0000-19,0003780-378
LEAP THERAPEUTICS INC354,166354,16601,4689420.61%-526
TERNS PHARMACEUTICALS INC555,260465,079-90,1813,6043,0511.98%-553
CELLECTAR BIOSCIENCES INC.477,500143,500-334,0001,3235710.37%-752
ARGENX SE - ADR(ARGX)2,4000-2,4009130-913
HILLEVAX INC324,600250,609-73,9915,2104,1682.71%-1,042
4D MOLECULAR THERAPEUTICS INC74,5000-74,5001,5090-1,509
ARCELLX INC
COMMON STOCK
77,00034,500-42,5004,2742,3991.56%-1,874
DISC MEDICINE INC(IRON)115,50076,800-38,7006,6714,7823.11%-1,890
IMMUNOVANT INC(IMVT)119,48992,346-27,1435,0342,9841.94%-2,050
ROCKET PHARMACEUTICALS INC366,015326,787-39,22810,9698,8045.72%-2,166
VIRIDIAN THERAPEUTICS INC(VRDN)281,500199,433-82,0676,1313,4922.27%-2,639
AN2 THERAPEUTICS INC132,0000-132,0002,7050-2,705
APELLIS PHARMACEUTICALS INC
COM
76,1000-76,1004,5550-4,555
KURA ONCOLOGY INC.(KURA)701,34990,000-611,34910,0851,9201.25%-8,166
EYEPOINT PHARMACEUTICALS INC(EYPT)425,1280-425,1289,8250-9,825
CYMABAY THERAPEUTICS INC492,1550-492,15511,6250-11,625
RAYZEBIO INC378,0690-378,06923,5050-23,505
Page 1 of 1